Uncategorized

Syncope Market Projected to Gain Significant Value by 2026

In medical terms, fainting or passing out caused by a fall in blood pressure is known as syncope. Syncope market is a temporary loss of muscle control and consciousness, usually related to insufficient blood flow to the brain. It most often occurs when blood pressure is very low. Syncope is also known as swooning or blacking out. It affects more women as compared to men. It also affects children, but in most cases, it is usually harmless. Neurological and heart problems are major factors that predispose children to serious syncope. As per literature review, 34%, or approximately 1/3 cases of syncope, are unexplained. Cardiac syncope is associated with a 6-month mortality rate.

Syncope can be classified into categories such as cardiogenic, neurological, metabolic, and vasomotor. Orthostatic hypotension is a common vasomotor cause of syncope. Transient ischemic attacks (TIAs), normal pressure hydrocephalus (NPH), and subclavian steal syndrome are major factors for neurological syncope. Heart valve disease, cardiac arrhythmias, and hypertrophic cardiomyopathy play a major role in cardio syncope.

Request Brochure of Syncope Market Report

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=51564

Head injury, inner ear problems, low blood sugar, problems with bowel movement, coughing, anemia, dehydration, pregnancy, stroke, breath holding episodes, and seizures are major situations or illnesses that can cause syncope.Changes in vision, dizziness, nausea, cold, damp skin, yawning, jerky and abnormal movements, and lightheadedness are common signs and symptoms of syncope.There is a focus on clinical history to diagnose syncope. Echocardiograms (echo), tilt table tests, electrocardiograms (ECG), cardiac magnetic resonance imaging, implantable heart monitors, electrophysiology study, and Holter monitors are major tests and procedures used to diagnose syncope. A major complication of syncope is sudden death.

Key players operating in the global syncope market include Medtronic, Inc., Philip Healthcare, Fukuda Denshi Co., Sanofi Aventis, GE Healthcare, Alba Medical Systems, Inc., Boehringer Ingelheim International GmbH, BIOTRONIK SE & Co. KG, Medicomp Inc., and OSI Systems, Inc..

Leave a Reply

Your email address will not be published. Required fields are marked *